Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2014 Giugno;26(2) > Minerva Biotecnologica 2014 Giugno;26(2):103-13

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

REVIEWS  MicroRNAs: from basic research to therapeutic applications


Minerva Biotecnologica 2014 Giugno;26(2):103-13

lingua: Inglese

MicroRNA “Theranostics”: technology transfer and clinical trials

Gambari R.

Section of Biochemistry and Molecular Biology, Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy


FULL TEXT  


MicroRNAs are very promising targets for diagnosis and prognosis of human pathologies. In addition, therapeutic molecules mimicking miRNA biological activity, or molecules inhibiting miRNA (antagomiRNAs) represent important tools for novel strategies to control and modify gene expression in eukaryotic systems, in vitro and in vivo. Therefore, miRNAs are key target in Teranostics. Among the molecules studied for “miRNA Therapeutics”, they are designed to mimic (miRNA replacement therapy) or to interfere with (antagomiRNA-based therapy) miRNA activity. Patents, patents applications and ongoing clinical trials based on miRNA targeting demonstrate the interest on this field of investigation for technology transfer.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

gam@unife.it